Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00218_DB00539_nanopub.RA6marehilg2NUfr3hRRWvtmC8gs_0I9xsIkmZmE4GX-Q#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00218_DB00539 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00218_DB00539 label "DDI between Moxifloxacin and Toremifene - Additive QTc-prolongation may occur, increasing the risk of serious ventricular arrhythmias. Consider alternate therapy. A thorough risk:benefit assessment is required prior to co-administration. [drugbank_resource:DB00218_DB00539]" assertion.
- drugbank_resource:DB00218_DB00539 identifier "drugbank_resource:DB00218_DB00539" assertion.
- drugbank_resource:DB00218_DB00539 title "DDI between Moxifloxacin and Toremifene - Additive QTc-prolongation may occur, increasing the risk of serious ventricular arrhythmias. Consider alternate therapy. A thorough risk:benefit assessment is required prior to co-administration." assertion.
- drugbank:DB00539 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00218_DB00539 assertion.
- drugbank:DB00218 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00218_DB00539 assertion.